Ladanyi M - Search Results

1

Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group.

Milewski D, Jung H, Brown GT, Liu Y, Somerville B, Lisle C, Ladanyi M, Rudzinski ER, Choo-Wosoba H, Barkauskas DA, Lo T, Hall D, Linardic CM, Wei JS, Chou HC, Skapek SX, Venkatramani R, Bode PK, Steinberg SM, Zaki G, Kuznetsov IB, Hawkins DS, Shern JF, Collins J, Khan J. Milewski D, et al. Among authors: ladanyi m. Clin Cancer Res. 2023 Jan 17;29(2):364-378. doi: 10.1158/1078-0432.CCR-22-1663. Clin Cancer Res. 2023. PMID: 36346688 Free PMC article.

2

Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.

Antonescu CR, Elahi A, Healey JH, Brennan MF, Lui MY, Lewis J, Jhanwar SC, Woodruff JM, Ladanyi M. Antonescu CR, et al. Among authors: ladanyi m. Clin Cancer Res. 2000 Jul;6(7):2788-93. Clin Cancer Res. 2000. PMID: 10914725

3

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks.

Khan J, Wei JS, Ringnér M, Saal LH, Ladanyi M, Westermann F, Berthold F, Schwab M, Antonescu CR, Peterson C, Meltzer PS. Khan J, et al. Among authors: ladanyi m. Nat Med. 2001 Jun;7(6):673-9. doi: 10.1038/89044. Nat Med. 2001. PMID: 11385503 Free PMC article.

4

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M. Antonescu CR, et al. Among authors: ladanyi m. Clin Cancer Res. 2001 Dec;7(12):3977-87. Clin Cancer Res. 2001. PMID: 11751490

5

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson B. Gorlick R, et al. Among authors: ladanyi m. Clin Cancer Res. 2003 Nov 15;9(15):5442-53. Clin Cancer Res. 2003. PMID: 14654523 Review.

6

Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.

Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Barbashina V, et al. Among authors: ladanyi m. Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179

7

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.

Riely GJ, Pao W, Pham D, Li AR, Rizvi N, Venkatraman ES, Zakowski MF, Kris MG, Ladanyi M, Miller VA. Riely GJ, et al. Among authors: ladanyi m. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):839-44. doi: 10.1158/1078-0432.CCR-05-1846. Clin Cancer Res. 2006. PMID: 16467097 Clinical Trial.

8

EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.

Antonescu CR, Nafa K, Segal NH, Dal Cin P, Ladanyi M. Antonescu CR, et al. Among authors: ladanyi m. Clin Cancer Res. 2006 Sep 15;12(18):5356-62. doi: 10.1158/1078-0432.CCR-05-2811. Clin Cancer Res. 2006. PMID: 17000668

9

Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.

Cheung IY, Feng Y, Danis K, Shukla N, Meyers P, Ladanyi M, Cheung NK. Cheung IY, et al. Among authors: ladanyi m. Clin Cancer Res. 2007 Dec 1;13(23):6978-83. doi: 10.1158/1078-0432.CCR-07-1417. Clin Cancer Res. 2007. PMID: 18056173

10

Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma.

Bean J, Riely GJ, Balak M, Marks JL, Ladanyi M, Miller VA, Pao W. Bean J, et al. Among authors: ladanyi m. Clin Cancer Res. 2008 Nov 15;14(22):7519-25. doi: 10.1158/1078-0432.CCR-08-0151. Clin Cancer Res. 2008. PMID: 19010870 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

736 results

Search Page